https://economictimes.indiatimes.com/markets/stocks/live-blog/bse-sensex-today-live-nifty-stock-market-updates-06-august-2025/liveblog/123130692.cms?from=mdr
Aug 6, 2025 - India’s benchmark indices Sensex and Nifty ended lower on Wednesday, dragged down by rate-sensitive stocks, after the Reserve Bank of India held key interest...
stock markethighlightssensexsettlespts
https://www.livemint.com/market/stock-market-news/q2-results-today-sun-pharma-grasim-ind-britannia-among-companies-to-declare-earnings-on-wednesday-5-nov-2025-11762309418073.html
Nov 5, 2025 - Sun Pharmaceutical Industries, Grasim Industries, Britannia Industries, Aurobindo Pharma, Delhivery are some of the marquee companies scheduled to post their...
sun pharmaresultstodayindbritannia
https://www.livemint.com/companies/sun-pharma-q1-preview-revenue-boost-11753882404095.html
India’s largest drugmaker, which has posted steady mid-to-high single digit growth for the last eight consecutive quarters, is expected to see its revenues...
sun pharmabiz growthpreviewhighdomestic
https://www.cnbctv18.com/market/stocks/semaglutide-patent-expiry-alankar-garude-of-kotak-institutional-equities-on-the-opportunity-for-indian-pharma-alpha-article-19814286.htm
Jan 5, 2026 - Kotak Institutional Equities’ Alankar Garude outlines pharma stock picks for 2026 as Semaglutide goes off patent in India and Canada, highlighting...
sun pharmaweight losslupinciplaamong
https://www.livemint.com/market/stock-market-news/ajanta-pharma-lupin-to-sun-pharma-why-are-pharma-stocks-falling-despite-trump-s-tariff-exemption-11756369290640.html
Aug 28, 2025 - Ajanta Pharma, Gland Pharma, Lupin, Aurobindo Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Divi's Laboratories and Torrent Pharmaceuticals...
pharmalupinsunstocks
https://www.livemint.com/market/mark-to-market/sun-pharma-investors-us-tariff-clarity-q2fy26-results-11762493881440.html
Nov 7, 2025 - India’s largest drugmaker posted modest profit growth in Q2FY26 as US sales fell and input costs rose. Investors now look for clarity on potential US import...
sun pharmainvestorsawaitclarityus
https://www.cnbctv18.com/market/stocks/systematics-groups-vishal-vanchinta-on-the-500-mn-glp-1-opportunity-for-indian-pharma-alpha-article-19812528.htm
Jan 2, 2026 - Vishal Manchanda, Pharma Analyst at Systematix Group, said that when it comes to investing in the GLP-1 theme, the Indian market offers greater predictability,...
sun pharmaerisbenefitcanadabrazil
https://www.zeebiz.com/market-news/photo-gallery-stocks-to-buy-sun-pharma-adani-ports-among-6-picks-tipped-for-big-gains-full-list-inside-386568
Dec 26, 2025 - Business News: Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the...
sun pharmaadani portsstocksbuyamong
https://www.pharmamedsstore.com/product/modalert-200-mg/?v=d41d8cd98f00
Nov 7, 2025 - Modalert is a modafinil product made by Sun Pharma.Buy Sun modalert 200mg online from Pharma Meds Store and get free shipping in USA
buysunpharmastore
https://www.propublica.org/article/fda-inspections-sun-pharma-drug-exemptions
Aug 12, 2025 - Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, exposing how the agency tolerated...
sun pharmaindianmadepromisesfda
https://www.zeebiz.com/markets/stocks/news-sun-pharma-set-for-strong-rally-morgan-stanley-sees-the-big-upside-384157
Nov 27, 2025 - Morgan Stanley maintained its Overweight rating on Sun Pharma. The brokerage has set a target price of Rs 2,026, indicating a possible upside from current...
sun pharmamorgan stanleysetstrongrally